Whipple's disease;De ziekte van Whipple

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 8, 1999, Pages 388-392

  Zaaijer, H L ^a   Savelkoul, P H M ^a   Broucke Grauls, C M J E Vanden ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE; STREPTOMYCIN;

ABDOMINAL PAIN; ANTIBIOTIC THERAPY; ARTHRALGIA; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; HUMAN; INTESTINE LIPODYSTROPHY; MALABSORPTION; PATHOGENESIS; REVIEW; TROPHERYMA WHIPPELII; WEIGHT REDUCTION;

ANTI-BACTERIAL AGENTS; BIOPSY; CULTURE TECHNIQUES; DRUG THERAPY, COMBINATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; WHIPPLE DISEASE;

EID: 0033585895     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Johns Hopkins Hospital Bulletin 1907; 18:382-91.
2. Dobbins WO. Whipple's disease. Springfield, Ill.: Charles C.Thomas, 1987.
3. Marth T, Neurath M, Cuccherini BA, Strober W. Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease. Gastroenterology 1997;113:442-8.
4. Frucht DM, Holland SM. Defective monocyte costimulation for 1FN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. J Immunol 1996;157:411-6.
5. Keinath RD, Merrell DE, Vlietstra R, Dobbins 3d WO. Antibiotic treatment and relapse in Whipple's disease. Long-term follow-up of 88 patients. Gastroenterology 1985;88:1867-73.
6. Feurle GE, Marth T. An evaluation of antimicrobial treatment for Whipple's disease. Tetracycline versus trimethoprim-sulfamethoxazole. Dig Dis Sci 1994;39:1642-8.
7. Dobbins WO. Whipple's disease. In: Mandell GL, Bennett JE, Dolin RG, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:1030-2.
8. Schnider PJ, Reisinger EC, Gerschlager W, Muller C, Berger T, Krejs GJ, et al. Long-term follow-up in cerebral Whipple's disease. Eur J Gastroenterol Hepatol 1996;8:899-903.
9. Cooper GS, Blades EW, Remler BF, Salata RA, Bennert KW, Jacobs GH. Central nervous system Whipple's disease: relapse during therapy with trimethoprim-sulfamethoxazole and remission with ceftixime. Gastroenterology 1994;106:782-6.
10. Wilson KH, Blitchington R, Frothingham R, Wilson JAP. Phylogeny of the Whipple's-disease-associated bacterium. Lancet 1991;338:474-5.
11. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992;327:293-301.
12. Harmsen D, Heesemann J, Brabletz T, Kirchner T, Mueller-Hermelink HK. Heterogeneity among Whipple's-disease-associated bacteria [letter]. Lancet 1994;343:1288.
13. Neumann K, Neumann V, Zierz S, Lahl R. Coinfection with Tropheryma whippelii and a Whipple's disease-associated bacterial organism detected in a patient with central nervous system Whipple's disease [letter]. J Clin Microbiol 1997;35:1645.
14. Hastier P, Buckley MJM, Raffaelli C, Delmont JP. A clue in the duodenum. Lancet 1997;350:1362.
15. Ramzan NN, Loftus jr E, Burgart LJ, Rooney M. Batts KP, Wiesner RH, et al. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med 1997;126:520-7.
16. Muller C, Stain C, Burghuber O. Tropheryma whippelii in peripheral blood mononuclear cells and cells of pleural effusion [letter]. Lancet 1993;341:701.
17. Marth T, Fredericks D, Strober W, Relman DA. Limited role for PCR-based diagnosis of Whipple's disease from peripheral blood mononuclear cells [letter]. Lancet 1996;348:66-7.
18. Schoedon G, Goldenberger D, Forrer R, Gunz A, Dutly F, Hochli M, et al. Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii. J Infect Dis 1997;176:672-7.